We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.87%
AUM
$99B
AUM Growth
+$5.31B
Cap. Flow
-$322M
Cap. Flow %
-0.32%
Top 10 Hldgs %
14.08%
Holding
2,651
New
81
Increased
1,135
Reduced
556
Closed
97

Sector Composition

Rank Sector Weight
1 Healthcare 14.05%
2 Technology 13.96%
3 Financials 13.95%
4 Industrials 9.13%
5 Energy 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPEN
1076
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
$3.6M ﹤0.01%
34,799
-13,700
-28% -$1.05M
GGG icon
1077
Graco
GGG
$13.3B
$3.59M ﹤0.01%
137,802
+1,797
+1% +$44.4K
HTWR
1078
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
$3.56M ﹤0.01%
40,213
+34,765
+638% +$3.11M
CENTA icon
1079
Central Garden & Pet Co Class A
CENTA
$2.42B
$3.56M ﹤0.01%
483,283
+69,509
+17% +$465K
STN icon
1080
Stantec
STN
$8.28B
$3.55M ﹤0.01%
114,578
+13,200
+13% +$399K
MOV icon
1081
Movado Group
MOV
$879M
$3.55M ﹤0.01%
85,129
+2,688
+3% +$108K
DNY
1082
DELISTED
DONNELLEY R R & SONS CO
DNY
$3.54M ﹤0.01%
208,868
KEX icon
1083
Kirby Corp
KEX
$7.08B
$3.52M ﹤0.01%
30,083
+700
+2% +$75.1K
SSNI
1084
DELISTED
Silver Spring Networks, Inc.
SSNI
$3.51M ﹤0.01%
263,608
-32,039
-11% -$437K
CBSH icon
1085
Commerce Bancshares
CBSH
$8.62B
$3.48M ﹤0.01%
134,350
ATO icon
1086
Atmos Energy
ATO
$28.8B
$3.47M ﹤0.01%
65,015
+900
+1% +$45.5K
RS icon
1087
Reliance Steel & Aluminium
RS
$21.2B
$3.47M ﹤0.01%
47,071
+800
+2% +$57.5K
LDRH
1088
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$3.46M ﹤0.01%
138,417
+18,695
+16% +$471K
ITGR icon
1089
Integer Holdings
ITGR
$4.25B
$3.44M ﹤0.01%
76,990
-22,890
-23% -$981K
HAE icon
1090
Haemonetics
HAE
$3.88B
$3.42M ﹤0.01%
97,038
+78,440
+422% +$2.62M
SLH
1091
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
$3.42M ﹤0.01%
50,967
+300
+0.6% +$19.5K
ROC
1092
DELISTED
ROCKWOOD HLDGS INC
ROC
$3.42M ﹤0.01%
45,023
+400
+0.9% +$29.4K
VIPS icon
1093
Vipshop
VIPS
$7.49B
$3.42M ﹤0.01%
182,100
-30,000
-14% -$481K
GNTX icon
1094
Gentex
GNTX
$5.14B
$3.4M ﹤0.01%
233,482
-9,400
-4% -$137K
SUNE
1095
DELISTED
SUNEDISON, INC COM
SUNE
$3.39M ﹤0.01%
150,092
+32,100
+27% +$624K
PEB icon
1096
Pebblebrook Hotel Trust
PEB
$2.15B
$3.36M ﹤0.01%
90,998
+2,700
+3% +$94.7K
BAGL
1097
DELISTED
EINSTEIN NOAH RESTAURANT GROUP, INC CMN STK (DELAWARE)
BAGL
$3.36M ﹤0.01%
208,982
+812
+0.4% +$12.6K
SPLK
1098
DELISTED
Splunk Inc
SPLK
$3.35M ﹤0.01%
60,475
+600
+1% +$31.5K
HUBG icon
1099
HUB Group
HUBG
$2.92B
$3.32M ﹤0.01%
131,904
-568
-0.4% -$12.9K
MKL icon
1100
Markel Group
MKL
$23.4B
$3.31M ﹤0.01%
5,051
+500
+11% +$315K

Similar funds

UBS AM's Q2 2014 Portfolio in Review

As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

  • UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
  • UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
  • UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
  • UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
  • UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
  • UBS AM opened 81 new positions and closed 97 in Q2 2014.
  • UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.

Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.